Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States.
Ragon Institute of Massachusetts General Hospital, Harvard, and MIT, Cambridge, United States.
Elife. 2023 Apr 19;12:e84070. doi: 10.7554/eLife.84070.
CD8+ T cell recognition of ()-specific peptides presented on major histocompatibility complex class I (MHC-I) contributes to immunity to tuberculosis (TB), but the principles that govern presentation of antigens on MHC-I are incompletely understood. In this study, mass spectrometry (MS) analysis of the MHC-I repertoire of -infected primary human macrophages reveals that substrates of 's type VII secretion systems (T7SS) are overrepresented among -derived peptides presented on MHC-I. Quantitative, targeted MS shows that ESX-1 activity is required for presentation of peptides derived from both ESX-1 substrates and ESX-5 substrates on MHC-I, consistent with a model in which proteins secreted by multiple T7SSs access a cytosolic antigen processing pathway via ESX-1-mediated phagosome permeabilization. Chemical inhibition of proteasome activity, lysosomal acidification, or cysteine cathepsin activity did not block presentation of antigens on MHC-I, suggesting involvement of other proteolytic pathways or redundancy among multiple pathways. Our study identifies antigens presented on MHC-I that could serve as targets for TB vaccines, and reveals how the activity of multiple T7SSs interacts to contribute to presentation of antigens on MHC-I.
CD8+ T 细胞对主要组织相容性复合体 I(MHC-I)上呈递的 ()-特异性肽的识别有助于对结核病(TB)的免疫,但调控抗原在 MHC-I 上呈递的原则尚未完全理解。在这项研究中,对感染的原代人巨噬细胞 MHC-I 库进行的质谱(MS)分析表明,在 MHC-I 上呈递的衍生肽中,()的 VII 型分泌系统(T7SS)的底物过度表达。定量靶向 MS 显示,ESX-1 活性对于在 MHC-I 上呈递源自 ESX-1 底物和 ESX-5 底物的肽是必需的,这与一种模型一致,即多个 T7SS 分泌的蛋白通过 ESX-1 介导的吞噬体通透进入细胞质抗原加工途径。蛋白酶体活性、溶酶体酸化或半胱氨酸组织蛋白酶活性的化学抑制并不阻止 MHC-I 上 ()抗原的呈递,这表明涉及其他蛋白水解途径或多个途径之间的冗余。我们的研究确定了在 MHC-I 上呈递的 ()抗原,这些抗原可作为结核病疫苗的靶标,并揭示了多种 T7SS 的活性如何相互作用以促进 ()抗原在 MHC-I 上的呈递。